Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00538226 · ClinicalTrials.gov registry record · Phase 1
Evaluation of the Effect of the Flowaid Device in Increasing Local Circulation in the Leg
A Phase 1 study of Peripheral Vascular Disease, sponsored by Rosenblum, Jonathan I., DPM.
- Completed
- Registry status
- Phase 1
- Development phase
- 1
- Study location
NCT00538226 is a Phase 1 study of Peripheral Vascular Disease that has completed, run by Rosenblum, Jonathan I., DPM. The trial reports 1 study location across 1 state.
The verdict
NCT00538226, a Phase 1 study of Peripheral Vascular Disease, has completed, sponsored by Rosenblum, Jonathan I., DPM.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 1
- Study location
Study Summary
This is an open label pilot study to evaluate the efficacy and the safety of the Flowaid device in increasing local circulation in the legs. 15 patients with a diagnosis of Peripheral Vascular Disease will be enrolled in this study. They will recieve tratment with the Flowaid device and monitored continuously by means of Laser Doppler Flowmetry as well as by tcPO2 and Digital Thermography. Subjective data will also be collected.
Conditions Studied
Interventions
- DEVICE External Electric Muscle Stimulation
Study Locations (1)
New York
- New York College of Podiatric Medicine - New York
Trial Details
| Field | Value |
|---|---|
| Start Date | 2007-10 |
| Est. Completion | 2007-11 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00538226
The ClinicalTrials.gov registry entry for NCT00538226 describes a study currently listed as completed, categorized as Phase 1. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Rosenblum, Jonathan I., DPM, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Peripheral Vascular Disease appearing as the primary indexed condition, and to 1 intervention - of which External Electric Muscle Stimulation is the first listed.
NCT00538226 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT00538226 about?
NCT00538226 is a clinical study titled "Evaluation of the Effect of the Flowaid Device in Increasing Local Circulation in the Leg". This is an open label pilot study to evaluate the efficacy and the safety of the Flowaid device in increasing local circulation in the legs. 15 patients with a diagnosis of Peripheral Vascular Disease will be enrolled in this study. They will recieve tratment with the Flowaid device and monitored c...
What is the current status of trial NCT00538226?
This trial is currently completed. It is a Phase 1 study. The study started on 2007-10. Estimated completion is 2007-11.
What conditions does trial NCT00538226 study?
This clinical trial studies the following conditions: Peripheral Vascular Disease.
What interventions are being tested in trial NCT00538226?
The interventions under investigation include: External Electric Muscle Stimulation (DEVICE).
Who is sponsoring clinical trial NCT00538226?
This trial is sponsored by Rosenblum, Jonathan I., DPM, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00538226 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Peripheral Vascular Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
BGC101 (EnEPC) Autologous Cell Therapy From Patient's Own Blood for Treatment of Critical Limb Ischemia (CLI)
ACTIVE NOT RECRUITING · Phase 1
-
A Clinical and Histological Analysis of Mesenchymal Stem Cells in Amputation
COMPLETED · Phase 1
-
ALD-301 for Critical Limb Ischemia, Randomized Trial
COMPLETED · Phase 1
-
Stem Cell Injection for Peripheral Vascular Disease
COMPLETED · Phase 1
-
Improving Mobility After Revascularization in Peripheral Artery Disease
RECRUITING · Phase 3
-
Far Red Light to Improve Functioning in PAD
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.